首页> 外文OA文献 >Development and Validation of a Versatile UPLC-PDA Method for Simultaneous Determination of Paracetamol, Tizanidine, Aceclofenac, and Nimesulide in Their New Combinations
【2h】

Development and Validation of a Versatile UPLC-PDA Method for Simultaneous Determination of Paracetamol, Tizanidine, Aceclofenac, and Nimesulide in Their New Combinations

机译:多功能UPLC-PDA方法同时测定扑热息痛,三氮胺酮,醋氯芬酸和尼美砜的开发和验证

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A simple, rapid, and validated UPLC method was developed for the simultaneous quantitation of paracetamol (PAR), tizanidine (TIZ), aceclofenac (ACF), and nimesulide (NIM) either in pure forms or in their different tablet dosage forms. Chromatographic separation was attained on an ACQUITY UPLC™ BEH C18 column (100 mm × 2.1 mm, 1.7 μm) with a mobile phase consisting of 20 mM phosphate buffer (pH 7.0) : acetonitrile in the proportion (60 : 40 v/v) isocratically pumped at a flow rate of 1.25 mL·min−1, and detection was monitored at 305 nm. All analytes were separated simultaneously at a retention time (tr) of 1.42, 2.31, 3.63, and 5.62 min for PAR, TIZ, ACF, and NIM, respectively, with a total run time less than 6.0 min. The proposed method was validated according to ICH guidelines with respect to accuracy, precision, linearity, limit of detection, limit of quantitation, and robustness. Linearity was obtained over a concentration range of 81.25–487.5, 0.5–3.5, 25–150, and 25–150 µg·mL−1 for PAR, TIZ, ACF, and NIM, respectively. The development method can be successfully employed in QC laboratories for the routine analysis of the investigated drugs in their new combination.
机译:开发了一种简单,快速和验证的UPLC方法,用于同时定量扑热氨基醇(PAR),钛烷(TIZ),乙烯烯烃(ACF)和尼米丁烷(ACF)和Nimesulide(Nim),其形式或其不同的片剂剂型。在Acquity UPLC™BEG C18柱(100mm×2.1mm,1.7μm)上获得色谱分离,其流动相由20mM磷酸盐缓冲液(pH7.0):乙腈(60:40 v / v)相当以1.25ml·min-1的流速泵送,并在305nm处监测检测。将所有分析物同时在1.42,2.31,3.63和5.62分钟的保留时间(TR)分别用于PAR,TIZ,ACF和NIM,总运行时间小于6.0分钟。根据ICH指南验证了所提出的方法,验证了关于准确性,精度,线性度,检测极限,定量限制和鲁棒性的准则。在81.25-487.5,0.5-3.5,25-150和25-150μg·ml-1的浓度范围内获得线性度,分别用于Par,Tiz,ACF和Nim。可以在QC实验室中成功地使用开发方法,以便在新组合中进行调查药物的常规分析。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号